Page-3 of Pharmaceutical Sector
Temperature controlled largest Terminal to store Agro and Pharma Products launched at Mumbai airport
The Mumbai airport has recently launched the world largest temperature-controlled facility to store agro and pharma products. The “Export Cold Zone” launched is capable of holding more than 700 tonnes of cargo. Highlights The terminal connects 500 cargo destinations spread ..
Month: Current Affairs - February, 2020
CSIR develop new technology of Geranium Production
CSIR (Council of Scientific and Industrial Research) has developed a new low-cost technology to produce Geranium saplings. Geranium acts as an anti-inflammatory and anti-septic agent. It has several medicinal values. The development has been made under Aroma Mission. About the ..
Month: Current Affairs - December, 2019
CSIR Nuclear Magnetic Resonance Test gets US FDA certification
The CSIR-IICT, Hyderabad on December 3, 2019, announced that the US Food and Drug Administration (USFDA) cleared the Nuclear Magnetic Resonance (NMR) Test facility at the centre. The inspection was conducted between August 21, 2019 and August 22, 2019 with ..
Month: Current Affairs - December, 2019
Guidelines for evaluation of Nano Pharmaceuticals released
Ministry of Science and Technology issued the “Guidelines for the Evaluation of Nano pharmaceuticals in India” on October 24, 2019. This is the most crucial step for delineating quality, safety and efficacy assessment of the novel nano formulations. The guidelines ..
Month: Current Affairs - October, 2019
China, India clinch deal to reduce tariffs on Indian medicines, anti-cancer drugs
China has announced that it has clinched deal with India on reduction of tariffs (import duties) on Indian medicines including anti-cancer drugs. However, it is not yet clear whether it has agreed to grant licences to Indian companies to sell ..
Month: Current Affairs - July, 2018
WHO launches plan for cheaper TB drugs
World Health Organization (WHO) has invited pharmaceutical companies around the world to submit proposals to manufacture affordable versions of newer medicines for treatment of drug resistant tuberculosis (DR-TB). It has now requested drug makers to submit Expression of Interest (EoI) ..